APP and Alzheimer disease: Cerebrovascular diseases have been suggested to contribute to AD neuropathological changes including selective brain atrophy and abnormal accumulation of proteins such as amyloid beta peptide (Aβ), which is described as the main toxic factor in AD (Hachinski et al., 2019).